The Clinical Times
The Front Page of Medicine

Latest medical news · page 52

The latest headlines across every section, pulled from official and open-access sources.

MedCity News · Jul 20, 2026

The Same AI That Helps Patients Is Being Used to Attack Them, Hospital Exec Says

As hospitals increasingly use AI to improve patient care, the same technology is being used by hackers and nation-states to launch faster, more sophisticated attacks. Karen Habercoss, chief information security and privacy officer at the University of Chicago Medicine, explained how her health system is building a governance structure to manage that risk. The post The Same AI That Helps Patients Is Being Used to Attack Them, Hospital Exec Says appeared first on MedCity News .

MedCity News · Jul 20, 2026

How Should Clinical AI Be Paid For? 3 Takeaways

A new report from the Peterson Health Technology Institute argues that today’s healthcare payment models are ill-suited for clinical AI and could drive up costs. The post How Should Clinical AI Be Paid For? 3 Takeaways appeared first on MedCity News .

MedCity News · Jul 20, 2026

Expecting Massive Test Growth in Cancer & More, Tempus AI Strikes $1.5B Deal to Buy Personalis

Personalis’s liquid biopsy is part of a growing market for minimal residual disease assays, tests that look for any remaining cancer cells after the initial treatment. Tempus AI has been the commercial partner on this Personalis test since 2023. The post Expecting Massive Test Growth in Cancer & More, Tempus AI Strikes $1.5B Deal to Buy Personalis appeared first on MedCity News .

ACC (Cardiology) · Jul 20, 2026

API-CAT Analysis: Recurrent VTE Uncommon, Associated With Poor Short-Term Survival

Recurrent venous thromboembolism (VTE) is uncommon but associated with poor short-term survival among patients with cancer-associated thrombosis on extended apixaban therapy after at least six months of anticoagulation treatment, according to a post-hoc analysis of the API-CAT trial published July 13 in Circulation.

FDA Drugs · Jul 20, 2026

Written Requests Issued

Updated list of approved active moieties to which FDA has issued a Written Request for pediatric studies

WHO · Jul 20, 2026

WHO marks 25 years of Research4Life, advancing access to scientific knowledge in more than 120 countries

The World Health Organization (WHO) today marks the 25th anniversary of Research4Life, a public-private partnership that provides researchers, educators, health professionals and policy-makers in low- and middle-income countries with affordable or free access to scientific knowledge. The partnership has helped dramatically expand access to scientific knowledge for researchers, educators, health professionals and policy-makers in more than 120 countries.

FDA Drugs · Jul 20, 2026

The Center for Research on Complex Generics

FDA awards a 5-year grant to the University of Maryland and the University of Michigan to establish a Center for Research on Complex Generics (CRCG).

BMJ Open · Jul 20, 2026

Technology-based interventions to promote physical activity in Gulf Cooperation Council (GCC) countries: a scoping review protocol

Introduction Physical inactivity is considered a major public health burden and remains highly prevalent across Gulf Cooperation Council (GCC) countries despite the rapid digital transformation and investment in health information infrastructure. Although technology-based interventions have emerged as promising approaches to promote physical activity, their implementation and impact are still unclear. This scoping review will map technology-based interventions that promote physical activity in the GCC against the domains of the Consolidated Framework for Implementation Research (CFIR) to…

BMJ Open · Jul 20, 2026

Safety and preliminary efficacy of allogeneic bone marrow-derived mesenchymal stromal cells (BMSC) for painful lumbar facet arthropathy: study protocol for a randomised, double-blinded, placebo-controlled, crossover phase II clinical trial

Background Lumbar facet arthropathy (LFA) is a degenerative, arthritic joint disorder and a common specific cause of axial low back pain and functional impairment. Currently, no disease-modifying therapies are available for symptomatic LFA. Mesenchymal stem/stromal cell (MSC)-based therapy represents an emerging regenerative treatment modality with the promise to target the underlying pathophysiology of LFA. Despite encouraging clinical evidence supporting the safety and efficacy of MSC therapy in other osteoarthritis, its therapeutic utility in LFA remains largely unexplored. We recently…

BMJ Open · Jul 20, 2026

Current situation and influencing factors of vicarious trauma among emergency trauma nurses in China: a latent profile analysis

Objective To identify the latent profiles of vicarious trauma among emergency trauma nurses in China and examine the factors associated with these profiles. Design A cross-sectional study. Setting 195 hospitals at Level 2 and above across 22 provincial-level administrative regions in China. Participants From January to March 2025, 930 emergency trauma nurses were recruited using a convenience sampling method (valid questionnaire response rate: 96.37%). All participants held a valid nursing practice certificate and had at least 1 year of trauma care experience. Primary and secondary outcome…

← NewerOlder →

Back to the live front page